260 related articles for article (PubMed ID: 7543439)
1. Differentiation and proliferative activity in benign and malignant cartilage tumors of bone.
Hasegawa T; Seki K; Yang P; Hirose T; Hizawa K; Wada T; Wakabayashi J
Hum Pathol; 1995 Aug; 26(8):838-45. PubMed ID: 7543439
[TBL] [Abstract][Full Text] [Related]
2. PAS inclusions, immunoreactive tenascin and proliferative activity in low-grade chondrosarcomas.
Ranty ML; Michot C; Le Pessot F; Hellot MF; Biga N; Dujardin FH; Simonet J; Billerey C; Metayer J
Pathol Res Pract; 2003; 199(1):29-34. PubMed ID: 12650515
[TBL] [Abstract][Full Text] [Related]
3. The identity of proliferating cells in bone tumors with cartilaginous components: evaluation by double-immunohistochemical staining using proliferating cell nuclear antigen and S-100 protein.
Chano T; Ishizawa M; Matsumoto K; Morimoto S; Hukuda S; Okabe H
Eur J Histochem; 1995; 39(1):21-30. PubMed ID: 7612954
[TBL] [Abstract][Full Text] [Related]
4. Type II collagen, but not aggrecan expression, distinguishes clear cell chondrosarcoma and chondroblastoma.
Söder S; Oliveira AM; Inwards CY; Müller S; Aigner T
Pathology; 2006 Feb; 38(1):35-8. PubMed ID: 16484006
[TBL] [Abstract][Full Text] [Related]
5. Absence of IHH and retention of PTHrP signalling in enchondromas and central chondrosarcomas.
Rozeman LB; Hameetman L; Cleton-Jansen AM; Taminiau AH; Hogendoorn PC; Bovée JV
J Pathol; 2005 Mar; 205(4):476-82. PubMed ID: 15685701
[TBL] [Abstract][Full Text] [Related]
6. Distinguishing chordoid meningiomas from their histologic mimics: an immunohistochemical evaluation.
Sangoi AR; Dulai MS; Beck AH; Brat DJ; Vogel H
Am J Surg Pathol; 2009 May; 33(5):669-81. PubMed ID: 19194275
[TBL] [Abstract][Full Text] [Related]
7. p53 expression and DNA ploidy of cartilage lesions.
Coughlan B; Feliz A; Ishida T; Czerniak B; Dorfman HD
Hum Pathol; 1995 Jun; 26(6):620-4. PubMed ID: 7774891
[TBL] [Abstract][Full Text] [Related]
8. Histological and immunohistochemical diversities, and proliferative activity and grading in osteosarcomas.
Hasegawa T; Hirose T; Seki K; Hizawa K; Ishii S; Wakabayashi J
Cancer Detect Prev; 1997; 21(3):280-7. PubMed ID: 9167046
[TBL] [Abstract][Full Text] [Related]
9. Analysis of angiogenic factors and cyclooxygenase-2 expression in cartilaginous tumors- clinical and histological correlation.
Cintra FF; Etchebehere M; Gonçalves JC; Cassone AE; Amstalden EM
Clinics (Sao Paulo); 2011; 66(9):1591-6. PubMed ID: 22179165
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone.
Masi L; Malentacchi C; Campanacci D; Franchi A
Virchows Arch; 2002 May; 440(5):491-7. PubMed ID: 12021923
[TBL] [Abstract][Full Text] [Related]
11. [Cartilage tumors of the skeleton].
Jundt G; Baumhoer D
Pathologe; 2008 Nov; 29 Suppl 2():223-31. PubMed ID: 18820927
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y
Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of angiogenesis and blood vessel maturation in cartilage tumors.
Kalinski T; Sel S; Kouznetsova I; Röpke M; Roessner A
Pathol Res Pract; 2009; 205(5):339-45. PubMed ID: 19157720
[TBL] [Abstract][Full Text] [Related]
14. Expression of leukemia inhibitory factor by cartilage-forming tumors of bone: an immunohistochemical study.
Gouin F; Moreau A; Couillaud S; Guicheux J; Passuti N; Godard A; Heymann D
J Orthop Res; 1999 Mar; 17(2):301-5. PubMed ID: 10221849
[TBL] [Abstract][Full Text] [Related]
15. ERG expression in chondrogenic bone and soft tissue tumours.
Shon W; Folpe AL; Fritchie KJ
J Clin Pathol; 2015 Feb; 68(2):125-9. PubMed ID: 25378537
[TBL] [Abstract][Full Text] [Related]
16. PTHrP and Bcl-2: essential regulatory molecules in chondrocyte differentiation and chondrogenic tumors.
Amling M; Pösl M; Hentz MW; Priemel M; Delling G
Verh Dtsch Ges Pathol; 1998; 82():160-9. PubMed ID: 10095428
[TBL] [Abstract][Full Text] [Related]
17. Immunolocalization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human chondrosarcomas.
Kawashima A; Okada Y; Nakanishi I; Ueda Y; Iwata K; Roessner A
Gen Diagn Pathol; 1997 Feb; 142(3-4):129-37. PubMed ID: 9065576
[TBL] [Abstract][Full Text] [Related]
18. Secondary chondrosarcoma in cartilage bone tumors: report of 32 patients.
Altay M; Bayrakci K; Yildiz Y; Erekul S; Saglik Y
J Orthop Sci; 2007 Sep; 12(5):415-23. PubMed ID: 17909925
[TBL] [Abstract][Full Text] [Related]
19. Expression of connective tissue growth factor in cartilaginous tumors.
Shakunaga T; Ozaki T; Ohara N; Asaumi K; Doi T; Nishida K; Kawai A; Nakanishi T; Takigawa M; Inoue H
Cancer; 2000 Oct; 89(7):1466-73. PubMed ID: 11013359
[TBL] [Abstract][Full Text] [Related]
20. Chondroblastoma of bone. A clinical, radiological, light and immunohistochemical study.
Edel G; Ueda Y; Nakanishi J; Brinker KH; Roessner A; Blasius S; Vestring T; Müller-Miny H; Erlemann R; Wuisman P
Virchows Arch A Pathol Anat Histopathol; 1992; 421(4):355-66. PubMed ID: 1384228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]